1. A phase 1 dose‐escalation study of filanesib plus bortezomib and dexamethasone in patients with recurrent/refractory multiple myeloma. Issue 21 (19th July 2016) Authors: Chari, Ajai; Htut, Myo; Zonder, Jeffrey A.; Fay, Joseph W.; Jakubowiak, Andrzej J.; Levy, Joan B.; Lau, Kenneth; Burt, Steven M.; Tunquist, Brian J.; Hilder, Brandi W.; Rush, Selena A.; Walker, Duncan H.; Ptaszynski, Mieke; Kaufman, Jonathan L. Journal: Cancer Issue: Volume 122:Issue 21(2016) Page Start: 3327 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase I study of intravenous plerixafor following cyclophosphamide mobilization in patients with multiple myeloma. Issue 1 (January 2014) Authors: Krishnan, Amrita Y.; Wang, Shirong; Palmer, Joycelynne M.; Tsai, Ni-Chun; Thomas, Sandra H.; Htut, Myo; Farol, Len; Forman, Stephen J. Journal: Leukemia & lymphoma Issue: Volume 55:Issue 1(2014:Jan.) Page Start: 201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study. Issue 10297 (24th July 2021) Authors: Berdeja, Jesus G; Madduri, Deepu; Usmani, Saad Z; Jakubowiak, Andrzej; Agha, Mounzer; Cohen, Adam D; Stewart, A Keith; Hari, Parameswaran; Htut, Myo; Lesokhin, Alexander; Deol, Abhinav; Munshi, Nikhil C; O'Donnell, Elizabeth; Avigan, David; Singh, Indrajeet; Zudaire, Enrique; Yeh, Tzu-Min; Allred... Journal: Lancet Issue: Volume 398:Issue 10297(2021) Page Start: 314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Filanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myeloma. (17th December 2021) Authors: Pan, Darren; Kaufman, Jonathan L.; Htut, Myo; Agrawal, Manish; Mazumder, Amitabha; Cornell, Robert F.; Zonder, Jeffrey A.; Fay, Joseph W.; Modiano, Manuel R.; Moshier, Erin L.; Rush, Selena A.; Tunquist, Brian J.; Chari, Ajai Journal: Cancer medicine Issue: Volume 11:Number 2(2022) Page Start: 358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Health-related quality of life in patients given ciltacabtagene autoleucel for relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b–2, open-label study. Issue 12 (December 2022) Authors: Martin, Thomas; Lin, Yi; Agha, Mounzer; Cohen, Adam D; Htut, Myo; Stewart, A Keith; Hari, Parameswaran; Berdeja, Jesus G; Usmani, Saad Z; Yeh, Tzu-Min; Olyslager, Yunsi; Goldberg, Jenna D; Schecter, Jordan M; Madduri, Deepu; Jackson, Carolyn C; Deraedt, William; Gries, Katharine S; Fastenau, John... Journal: Lancet Issue: Volume 9:Issue 12(2022) Page Start: e897 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Kaposi sarcoma after non-myeloablative hematopoietic stem cell transplant: response to withdrawal of immunosuppressant therapy correlated with whole blood human herpesvirus-8 reverse transcriptase-polymerase chain reaction levels. Issue 10 (October 2013) Authors: Deauna-Limayo, Delva; Rajabi, Babak; Qiu, Wansong; Htut, Myo; Sweetenham, John Journal: Leukemia & lymphoma Issue: Volume 54:Issue 10(2013:Oct.) Page Start: 2299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Late relapses following reduced intensity allogeneic transplantation in patients with multiple myeloma: a long‐term follow‐up study. (15th November 2012) Authors: Sahebi, Firoozeh; Shen, Yan; Thomas, Sandra H.; Rincon, Amalia; Murata‐Collins, Joyce; Palmer, Joycelynne; Krishnan, Amrita Y.; Karanes, Chatchada; Htut, Myo; Somlo, George; Forman, Stephen J. Journal: British journal of haematology Issue: Volume 160:Number 2(2013:Jan.) Page Start: 199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Repurposing leflunomide for relapsed/refractory multiple myeloma: a phase 1 study. Issue 7 (6th June 2020) Authors: Rosenzweig, Michael; Palmer, Joycelynne; Tsai, Ni-Chun; Synold, Tim; Wu, Xiwei; Tao, Shu; Hammond, Samantha N.; Buettner, Ralf; Duarte, Lupe; Htut, Myo; Karanes, Chatchada; Nathwani, Nitya; Pichiorri, Flavia; Sahebi, Firoozeh; Sanchez, James F.; Chowdhury, Arnab; Krishnan, Amrita; Forman, Stephen... Journal: Leukemia & lymphoma Issue: Volume 61:Issue 7(2020) Page Start: 1669 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Twice‐weekly ixazomib in combination with lenalidomide‐dexamethasone in patients with newly diagnosed multiple myeloma. (25th June 2018) Authors: Richardson, Paul G.; Hofmeister, Craig C.; Rosenbaum, Cara A.; Htut, Myo; Vesole, David H.; Berdeja, Jesus G.; Liedtke, Michaela; Chari, Ajai; Smith, Stephen D.; Lebovic, Daniel; Raje, Noopur; Byrne, Catriona; Liao, Eileen; Gupta, Neeraj; Bacco, Alessandra Di; Estevam, Jose; Berg, Deborah; Baz, R... Journal: British journal of haematology Issue: Volume 182:Number 2(2018) Page Start: 231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗